Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
13.78
-0.19 (-1.36%)
At close: Mar 18, 2026, 4:00 PM EDT
14.05
+0.27 (1.96%)
After-hours: Mar 18, 2026, 5:57 PM EDT
Jade Biosciences Market Cap
Jade Biosciences has a market cap or net worth of $679.58 million as of March 18, 2026.
Market Cap
679.58M
Enterprise Value
344.14M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.78
Market Cap Chart
Since April 29, 2025, Jade Biosciences's market cap has increased from $326.87M to $679.58M, an increase of 107.90%. That is a compound annual growth rate of 129.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 688.95M | -2.94% |
| Dec 31, 2025 | 709.84M | 117.16% |
| Apr 29, 2025 | 326.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 727.50M |
| Bright Minds Biosciences | 719.99M |
| Lexicon Pharmaceuticals | 716.02M |
| Alto Neuroscience | 711.11M |
| Theravance Biopharma | 698.27M |
| Annexon | 677.12M |
| ProKidney | 676.88M |
| AgomAb Therapeutics NV | 675.00M |